Blood donor selection in European Union directives: Room for improvement

Blood Transfusion

Volumn 14, Issue 2, 2016, Pages 101-108

  De Kort, Wim ^a   Mayr, Wolfgang ^b   Jungbauer, Christof ^b   Vuk, Tomislav ^c   Kullaste, Riin ^d   Seifried, Erhard ^e   Grazzini, Giuliano ^f   De Wit, Jeroen ^a   Folléa, Gilles ^g  

^a CENTRAL LABORATORY   (Netherlands)

^b Red Cross Blood Transfusion Service of Upper Austria   (Austria)

^c CROATIAN INSTITUTE OF TRANSFUSION MEDICINE   (Croatia)

^d North Estonia Medical Centre   (Estonia)

^e German Red Cross Blood Service   (Germany)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g Blood Consult GF   (France)

Author keywords

Blood donor; EU directive; Evidence based medicine; Selection criteria

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DONOR SELECTION; EPIDEMIOLOGICAL DATA; EUROPEAN UNION; HEALTH HAZARD; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION; INFECTION RISK; LABORATORY TEST; PATIENT REFERRAL; PATIENT SAFETY; PRACTICE GUIDELINE; QUESTIONNAIRE; RANDOM SAMPLE; RISK ASSESSMENT; RISK REDUCTION; SCREENING TEST; TATTOOING; TRANSFUSION; VASCULARIZATION; WORLD HEALTH ORGANIZATION; FEMALE; INFECTION CONTROL; LEGISLATION AND JURISPRUDENCE; MALE; ORGANIZATION AND MANAGEMENT; STANDARDS; TRANSMISSION;

BLOOD DONORS; DONOR SELECTION; EUROPEAN UNION; FEMALE; HUMANS; INFECTION; INFECTION CONTROL; MALE;

EID: 84961641644     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2015.0148-15     Document Type: Article

References (34)

1. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood 2008; 11 2: 2617-26.
2. Stramer SL, Dodd RY, Subgroup AT-TDEID. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion 2013; 53: 2375-83.
3. Ngo LT, Bruhn R, Custer B. Risk perception and its role in attitudes toward blood transfusion: a qualitative systematic review. Transfus Med Rev 2013; 27: 119-28.
4. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. OJ, L33, 8/2/2003, p. 30.
5. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. OJ, L91, 30/3/2004, p. 25.
6. th ed. Strasbourg: Council of Europe Publishing; 2013.
7. Menitove JE, Leach Bennett J, Tomasulo P, Katz LM. How safe is safe enough, who decides and how? From a zero-risk paradigm to risk-based decision making. Transfusion 2014; 54: 753-7.
8. Eichler HG, Bloechl-Daum B, Brasseur D, et al. The risks of risk aversion in drug regulation. Nat Rev Drug Discov 2013; 12: 907-16.
9. th, 2015). Available at: http://curia.europa.eu/juris/document/document.jsf?text=&docid=164021&pageIndex=0&doclang=EN&mode=lst&dir=&occ=first&part=1&cid=357418. Accessed on 27/09/2015.
10. Tan-Torres Edjer T, Baltussen R, Adam T et al., editors. Making choices in health: WHO guide to cost-effectiveness analysis. World Health Organization: Geneva; 2003.
11. National Institute for Health and Clinical Excellence. Social Value Judgements: Principles for the development of NICE guidance. NICE: London; 2012.
12. Murphy W. Managing threats rather than risks in blood transfusion: robust design for a complex system. Transfusion 2006; 46: 2011-3.
13. Murphy WG Of mad cows and bolted horses: the economics of blood safety. Transfusion 2012; 52: 2278-81.
14. European Commission. Road safety: EU reports lowest ever number of road deaths and takes first step towards an injuries strategy. Brussels, 2013. Available at: http://europa.eu/rapid/press-release-IP-13-236-en.htm. Accessed on 27/09/2015.
15. Central Intelligence Agency. Death rate. 2015. Available at: http://www.indexmundi.com/european-union/death-rate.html. Accessed on dd/mm/yyyy.
16. United Nations Office of Drugs and Crime. UNODC Global Study on Homicide 2013. Vienna, 2014. Available at: https://www.unodc.org/documents/gsh/pdfs/2014-GLOBAL-HOMICIDE-BOOK-web.pdf. Accessed on 27/09/2015.
17. World Health Organization Regional office for Europe. Data and statistics. 2015. Available at: http://www.euro.who.int/en/health-topics/communicable-diseases/hepatitis/data-and-statistics. Accessed on 27/09/2015.
18. Borkent-Raven BA, Janssen MP, van der Poel CL, et al. Cost-effectiveness of additional blood screening tests in the Netherlands. Transfusion 2012; 52: 478-88.
19. Urbanus AT, van den Hoek A, Boonstra A, et al. People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands. PLoS. One 2011; 6: e24736.
20. O'Brien SF, Xi G, Fan W, et al. Are donors in Canada compliant with deferral for tattoos and piercing? Blood Transfus 2014; 12: 141-2.
21. Atsma F, Veldhuizen I, Verbeek A, et al. Healthy donor effect: its magnitude in health research among blood donors. Transfusion 2011; 51: 1820-8.
22. Golding J, Northstone K, Miller LL, et al. Differences between blood donors and a population sample: implications for case-control studies. Int J Epidemiol 2013; 42: 1145-56.
23. de Kort W, van den Burg P, Geerligs H, et al. Cost-effectiveness of questionnaires in preventing transfusion-transmitted infections. Transfusion 2014; 54: 879-88.
24. Busch MP, Glynn SA, Stramer SL, et al, Group N-RNS. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254-64.
25. Pillonel J, Laperche S. Estimating residual risks of transfusion-transmitted HIV-1 and HVC infection in France. ISBT Congress, London, 2015.
26. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA 1997; 277: 967-72.
27. Goldman M, Yi QL, Ye X, et al. Donor understanding and attitudes about current and potential deferral criteria for high-risk sexual behavior. Transfusion 2011; 51: 1829-34.
28. Gorlin J. Iron man pentathlon or "we have met the enemy and they is us!". Transfusion 2014; 54: 747-9.
29. Baart AM, van Noord PAH, Vergouwe Y, et al. High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion 2013; 53: 1670-7.
30. van Dongen A, Abraham C, Ruiter RAC, Veldhuizen IJT The influence of adverse reactions, subjective distress, and anxiety on retention of first-time blood donors. Transfusion 2013; 53: 337-43.
31. Committee of Ministers - Council of Europe. Resolution CM/Res(2013)3 on sexual behaviours of blood donors that have an impact on transfusion safety, 2013. Available at https://wcd.coe.int/ViewDoc.jsp?id=2051047. Accessed on dd/mm/yyyy.
32. Offergeld R, Kamp C, Heiden M, et al. Sexual risk behaviour and donor deferral in Europe. Vox Sang 2014; 107: 420-7.
33. Epstein J, Ganz PR, Seitz R, et al. A shared regulatory perspective on deferral from blood donation of men who have sex with men (MSM). Vox Sang 2014; 107: 416-9.
34. Davison KL, Conti S, Brailsford SR. The risk of transfusion-transmitted HIV from blood donations of men who have sex with men, 12 months after last sex with a man: 2005-2007 estimates from England and Wales. Vox Sang 2013; 105: 85-8.